STOCK TITAN
  1. Home
  2. Sec-filings
  3. IDXX
  4. [Form 4] IDEXX LABORATORIES INC /DE Insider Trading Activity

IDEXX (IDXX) director Lawrence Kingsley awarded RSUs and stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IDEXX Laboratories director Lawrence D. Kingsley reported multiple equity awards. On May 12, 2026, he received grants of restricted stock units covering 75 and 234 shares of common stock. Each unit represents a contingent right to receive one share.

He was also granted non-qualified stock options for 168 and 525 shares of common stock at an exercise price of $533.92 per share. According to the footnotes, these RSUs and options vest in a single installment on the one-year anniversary of the grant date or on the date of IDEXX’s 2027 annual meeting of shareholders, whichever occurs earlier. The options expire on May 11, 2036.

Positive

  • None.

Negative

  • None.
Insider Kingsley Lawrence D
Role null
Type Security Shares Price Value
Grant/Award Non-Qualified Stock Option (right-to-buy) 525 $0.00 --
Grant/Award Non-Qualified Stock Option (right-to-buy) 168 $0.00 --
Grant/Award Restricted Stock Unit 234 $0.00 --
Grant/Award Restricted Stock Unit 75 $0.00 --
Holdings After Transaction: Non-Qualified Stock Option (right-to-buy) — 525 shares (Direct, null); Restricted Stock Unit — 234 shares (Direct, null)
Footnotes (1)
  1. Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Additional grant as Lead Director. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.
RSU grant 1 75 units Restricted stock units, underlying 75 common shares, granted May 12, 2026
RSU grant 2 234 units Restricted stock units, underlying 234 common shares, granted May 12, 2026
Option grant 1 168 options at $533.92 Non-qualified stock options on 168 shares, exercise price $533.92
Option grant 2 525 options at $533.92 Non-qualified stock options on 525 shares, exercise price $533.92
Option expiration May 11, 2036 Expiration date for reported non-qualified stock options
Vesting trigger 1 year or 2027 meeting Awards vest on one-year anniversary of grant or 2027 annual meeting
Restricted Stock Unit financial
"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right-to-buy) with an exercise price of 533.9200."
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."
annual meeting of shareholders financial
"Vests on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders."
A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.
Lead Director financial
"Additional grant as Lead Director."
A lead director is a board member chosen by other independent directors to coordinate the board’s independent oversight of company management, acting like a team captain or referee who organizes meetings, leads discussions without the CEO present, and serves as a primary contact between independent directors and company leadership. Investors care because a strong lead director helps prevent conflicts of interest, improves decision-making and accountability, and signals that the board is actively watching how management runs the business.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kingsley Lawrence D
(Last)(First)(Middle)
ONE IDEXX DRIVE
(Street)
WESTBROOK MAINE 04092
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right-to-buy)$533.9205/12/2026A525 (1)05/11/2036Common Stock525$0525D
Non-Qualified Stock Option (right-to-buy)$533.9205/12/2026A168(2) (1)05/11/2036Common Stock168$0168D
Restricted Stock Unit(3)05/12/2026A234 (3) (3)Common Stock234$0234D
Restricted Stock Unit(3)05/12/2026A75(2) (3) (3)Common Stock75$075D
Explanation of Responses:
1. Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.
2. Additional grant as Lead Director.
3. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.
Remarks:
/s/ Lily J. Lu, Attorney-in-Fact for Lawrence D. Kingsley05/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did IDEXX (IDXX) director Lawrence Kingsley report?

Lawrence D. Kingsley reported equity awards, not open-market trades. On May 12, 2026, he received grants of restricted stock units and non-qualified stock options linked to IDEXX common stock, all as compensation-related awards rather than purchases or sales in the market.

How many restricted stock units did Kingsley receive in this IDEXX (IDXX) Form 4?

He received two restricted stock unit grants covering 75 and 234 underlying shares of IDEXX common stock. Each restricted stock unit represents a contingent right to receive one share, subject to vesting based on the timetable tied to the grant date and 2027 annual meeting.

What stock options were granted to Lawrence Kingsley at IDEXX (IDXX)?

He was granted non-qualified stock options for 168 and 525 shares of IDEXX common stock at an exercise price of $533.92 per share. These options are compensation awards, not exercises, and remain outstanding subject to vesting and an expiration date in May 2036.

When do Lawrence Kingsley’s IDEXX (IDXX) equity awards vest?

The footnotes state the restricted stock units and option grants vest in one installment on the one-year anniversary of the May 12, 2026 grant date or on the date of IDEXX’s 2027 annual meeting of shareholders, whichever event happens first under the award terms.

What does each restricted stock unit represent in the IDEXX (IDXX) Form 4?

Each restricted stock unit represents a contingent right to receive one share of IDEXX common stock upon vesting. The units are not actual shares until they vest, at which time they can settle into shares based on the conditions described in the award documentation.

When do Kingsley’s IDEXX (IDXX) stock options expire and at what price?

The non-qualified stock options reported have an exercise price of $533.92 per share and an expiration date of May 11, 2036. They are only exercisable once vested, according to the single-installment vesting schedule tied to the one-year anniversary or 2027 annual meeting.